Skip to content
DataLookout
Menu

NCT06267365

Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria shortened, about 5 words Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion pushed from Mar 1, 2027 to May 1, 2027
    • Final enrollment: 25 participants (planned 100)
    • Study completion pushed from Jun 1, 2028 to Dec 1, 2028
    • Secondary endpoints: details revised at 51 of 60 entries
    • Site details revised
  2. Notable Primary completion date: Jan 1, 2026 to Mar 1, 2027v3
  3. Notable Primary completion date: Jun 1, 2025 to Jan 1, 2026
    • Eligibility criteria expanded, about 7 words
    • Study completion date: Sep 1, 2025 to Jun 1, 2028
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change from Baseline in Brief Pain Inventory (BPI) Score at Month 3 Post-Operation
Timeframe: Baseline, Month 3 Post-Operation

Secondary (60)

Change from Baseline in BPI Score at Month 6 Post-Operation
Change from Baseline in BPI Score at Month 12 Post-Operation
Change from Baseline in BPI Score at Month 18 Post-Operation
Change from Baseline in Patient Reported Outcome System (PROMIS) - Physical Function - Short Form 6b Score at Month 3 Post-Operation
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 6 Post-Operation
Show 55 moreShow less
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 12 Post-Operation
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 18 Post-Operation
Number of Participants who use Opioids at Baseline
Number of Participants who use Opioids at Month 3
Number of Participants who use Opioids at Month 6
Number of Participants who use Opioids at Month 12
Number of Participants who use Opioids at Month 18
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 3 Post-Procedure
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 6 Post-Procedure
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 12 Post-Procedure
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 18 Post-Procedure
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 3 Post-Procedure
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 6 Post-Procedure
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 12 Post-Procedure
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 18 Post-Procedure
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 3 Post-Procedure
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 6 Post-Procedure
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 12 Post-Procedure
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 18 Post-Procedure
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 3 Post-Procedure
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 6 Post-Procedure
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 12 Post-Procedure
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 18 Post-Procedure
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 3 Post-Procedure
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 6 Post-Procedure
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 12 Post-Procedure
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 18 Post-Procedure
Change from Baseline in Pain Catastrophizing Scale (PCS) Score at Month 3 Post-Procedure
Change from Baseline in PCS Score at Month 6 Post-Procedure
Change from Baseline in PCS Score at Month 12 Post-Procedure
Change from Baseline in PCS Score at Month 18 Post-Procedure
Change from Baseline in Sleep Duration at Month 3 Post-Procedure
Change from Baseline in Sleep Duration at Month 6 Post-Procedure
Change from Baseline in Sleep Duration at Month 12 Post-Procedure
Change from Baseline in Sleep Duration at Month 18 Post-Procedure
Change from Baseline in Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) Score at Month 3 Post-Procedure
Change from Baseline in TAPS Score at Month 6 Post-Procedure
Change from Baseline in TAPS Score at Month 12 Post-Procedure
Change from Baseline in TAPS Score at Month 18 Post-Procedure
Change from Baseline in Patient Global Impression of Change (PGIC) Score at Month 3 Post-Procedure
Change from Baseline in PGIC Score at Month 6 Post-Procedure
Change from Baseline in PGIC Score at Month 12 Post-Procedure
Change from Baseline in PGIC Score at Month 18 Post-Procedure
Change from Baseline in Patient Health Questionnaire-2 (PHQ-2) Score at Month 3 Post-Procedure
Change from Baseline in PHQ-2 Score at Month 6 Post-Procedure
Change from Baseline in PHQ-2 Score at Month 12 Post-Procedure
Change from Baseline in PHQ-2 Score at Month 18 Post-Procedure
Change from Baseline in Generalized Anxiety Disorder 2 (GAD-2) Score at Month 3 Post-Procedure
Change from Baseline in GAD-2 Score at Month 6 Post-Procedure
Change from Baseline in GAD-2 Score at Month 12 Post-Procedure
Change from Baseline in GAD-2 Score at Month 18 Post-Procedure
Change from Baseline in Pain, Enjoyment of Life and General Activity (PEG) Scale at Month 3 Post-Procedure
Change from Baseline in PEG Scale at Month 6 Post-Procedure
Change from Baseline in PEG Scale at Month 12 Post-Procedure
Change from Baseline in PEG Scale at Month 18 Post-Procedure

Arms and interventions

Adult Patients with Painful Chronic Pancreatitis

Participants with chronic pancreatitis scheduled for endoscopic therapy will undergo baseline assessments including EEG, quantitative sensory testing, and psychosocial questionnaires. Follow-up questionnaires will be completed at approximately 3, 6, 12 and 18 months post-procedure.

Sites

1 site in 1 country

  • NYU Langone HealthNew York, New York, United States